ArticleThe European respiratory journal2022

Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·µL

Klaus F Rabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.